Table 2.

AREG, Minnesota risk score, and clinical outcomes: multivariate regression

FactorNOR of CR/PR95% CIPHazard ratio of 2-y OS95% CIPHazard ratio of 2-y NRM95% CIP
Minnesota risk/AREG           
 SR, low AREG 102 1.00*   1.00*   1.00*   
 SR, high AREG 92 0.41 0.20-0.84 .02 2.30 1.48-3.58 <.01 3.62 1.93-6.78 <.01 
 HR, low AREG 18 0.89 0.22-3.61 .87 1.44 0.63-3.30 .39 1.14 0.23-5.62 .87 
 HR, high AREG 39 0.18 0.08-0.44 <.01 3.35 1.94-5.79 <.01 7.17 3.40-15.14 <.01 
 Age − (/decade) 251 1.18 0.96-1.45 .11 1.20 1.05-1.37 .01 1.44 1.19-1.74 <.01 
Donor type           
 HLA-matched sibling 91 1.00*   1.00*   1.00*   
 Other related 18 4.77 0.58-39.7 .15 1.31 0.63-2.72 .47 1.41 0.58-3.41 .45 
 URD 124 0.58 0.30-1.15 .12 1.27 0.84-1.91 .26 1.22 0.72-2.07 .46 
 UCB 18 1.56 0.36-6.67 .55 0.72 0.32-1.64 .44 1.00 0.37-2.71 .99 
FactorNOR of CR/PR95% CIPHazard ratio of 2-y OS95% CIPHazard ratio of 2-y NRM95% CIP
Minnesota risk/AREG           
 SR, low AREG 102 1.00*   1.00*   1.00*   
 SR, high AREG 92 0.41 0.20-0.84 .02 2.30 1.48-3.58 <.01 3.62 1.93-6.78 <.01 
 HR, low AREG 18 0.89 0.22-3.61 .87 1.44 0.63-3.30 .39 1.14 0.23-5.62 .87 
 HR, high AREG 39 0.18 0.08-0.44 <.01 3.35 1.94-5.79 <.01 7.17 3.40-15.14 <.01 
 Age − (/decade) 251 1.18 0.96-1.45 .11 1.20 1.05-1.37 .01 1.44 1.19-1.74 <.01 
Donor type           
 HLA-matched sibling 91 1.00*   1.00*   1.00*   
 Other related 18 4.77 0.58-39.7 .15 1.31 0.63-2.72 .47 1.41 0.58-3.41 .45 
 URD 124 0.58 0.30-1.15 .12 1.27 0.84-1.91 .26 1.22 0.72-2.07 .46 
 UCB 18 1.56 0.36-6.67 .55 0.72 0.32-1.64 .44 1.00 0.37-2.71 .99 

Bold values are statistically significant.

*

Reference group.

or Create an Account

Close Modal
Close Modal